Introduction
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune demyelinating disorder of the central nervous system that was previously thought to be a subtype of multiple sclerosis (MS). The identification of a serological biomarker for the aquaporin-4 antibody in up to 80% of NMOSD patients with near 100% specificity separate these two disorders into distinct clinical entities (Zekeridou and Lennon, 2015) . Historically, NMOSD was thought to include a monophasic group with simultaneous involvement of the optic nerve and the spinal cord in a single attack (Jarius and Wildemann, 2013) . Since the discovery of the aquaporin-4 antibody, however, all seropositive NMOSD patients are recognized to be at high risk for a potentially disabling relapse. It is therefore of crucial importance to accurately diagnose NMOSD and differentiate it from multiple sclerosis to allow proper management of acute exacerbations as well as prevention of further relapses.
NMOSD is rare as a percentage of all autoimmune demyelinating diseases and in total number. Its prevalence rarely exceeds 5 per 100,000 (Mori et al., 2018) . In a recent review of literature (Pandit et al., 2015) , the reported prevalence of NMO in different parts of the world ranged from 0.51 per 100,000 in Cuba to 4.4 in Southern Denmark and the incidence ranged from 0.053 per 100,000 per year in Cuba to 0.4 in Southern Denmark (Etemadifar et al., 2015) . There is a strong female predominance varying from 2.27:1 in Isfahan, Iran, to 9.8:1 in French West Indies (Asgari et al., 2011; Cossburn et al., 2012; Etemadifar et al., 2014; Jacob et al., 2013; Cabre et al., 2009) .
The Middle East is a politically defined region of the world that stretches from northwest Africa to Pakistan. 
